Novo Nordisk A/S (BKK:NOVOB80)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of THB 6.97 trillion. The enterprise value is 7.36 trillion.

Market Cap	6.97T
Enterprise Value	7.36T

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.18B

Valuation Ratios

The trailing PE ratio is 13.54 and the forward PE ratio is 12.14.

PE Ratio	13.54
Forward PE	12.14
PS Ratio	4.67
PB Ratio	10.23
P/TBV Ratio	48.59
P/FCF Ratio	17.90
P/OCF Ratio	10.80
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.36, with an EV/FCF ratio of 18.90.

EV / Earnings	14.30
EV / Sales	4.84
EV / EBITDA	9.36
EV / EBIT	9.99
EV / FCF	18.90

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.86.

Current Ratio	0.74
Quick Ratio	0.54
Debt / Equity	0.86
Debt / EBITDA	0.76
Debt / FCF	1.50
Interest Coverage	41.95

Financial Efficiency

Return on equity (ROE) is 88.12% and return on invested capital (ROIC) is 47.91%.

Return on Equity (ROE)	88.12%
Return on Assets (ROA)	23.29%
Return on Invested Capital (ROIC)	47.91%
Return on Capital Employed (ROCE)	58.02%
Revenue Per Employee	19.27M
Profits Per Employee	6.65M
Employee Count	77,349
Asset Turnover	0.77
Inventory Turnover	1.22

Taxes

In the past 12 months, Novo Nordisk has paid 136.25 billion in taxes.

Income Tax	136.25B
Effective Tax Rate	20.93%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	2.26
200-Day Moving Average	n/a
Relative Strength Index (RSI)	27.46
Average Volume (20 Days)	5,379,073

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of THB 1.49 trillion and earned 514.74 billion in profits. Earnings per share was 115.52.

Revenue	1.49T
Gross Profit	1.26T
Operating Income	722.42B
Pretax Income	650.99B
Net Income	514.74B
EBITDA	764.05B
EBIT	722.42B
Earnings Per Share (EPS)	115.52

Balance Sheet

The company has 204.44 billion in cash and 584.16 billion in debt, giving a net cash position of -379.72 billion.

Cash & Cash Equivalents	204.44B
Total Debt	584.16B
Net Cash	-379.72B
Net Cash Per Share	n/a
Equity (Book Value)	681.66B
Book Value Per Share	153.55
Working Capital	-303.69B

Cash Flow

In the last 12 months, operating cash flow was 645.77 billion and capital expenditures -256.41 billion, giving a free cash flow of 389.36 billion.

Operating Cash Flow	645.77B
Capital Expenditures	-256.41B
Free Cash Flow	389.36B
FCF Per Share	n/a

Margins

Gross margin is 84.65%, with operating and profit margins of 48.43% and 34.51%.

Gross Margin	84.65%
Operating Margin	48.43%
Pretax Margin	43.65%
Profit Margin	34.51%
EBITDA Margin	51.23%
EBIT Margin	48.43%
FCF Margin	26.10%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 1.73%.

Dividend Per Share	0.03
Dividend Yield	1.73%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	48.61%
Buyback Yield	0.61%
Shareholder Yield	2.34%
Earnings Yield	7.38%
FCF Yield	5.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novo Nordisk has an Altman Z-Score of 7.88 and a Piotroski F-Score of 5.

Altman Z-Score	7.88
Piotroski F-Score	5